{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:28:43Z","timestamp":1791293323097,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Brazilian Research Development Council (CNPQ)","award":["402822\/2005-6"],"award-info":[{"award-number":["402822\/2005-6"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12936-015-0998-3","type":"journal-article","created":{"date-parts":[[2015,11,26]],"date-time":"2015-11-26T12:21:38Z","timestamp":1448540498000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Dispensing and determinants of non-adherence to treatment for non complicated malaria caused by Plasmodium vivax and Plasmodium falciparum in high-risk municipalities in the Brazilian Amazon"],"prefix":"10.1186","volume":"14","author":[{"given":"Claudia G. S.","family":"Osorio-de-Castro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha C.","family":"Su\u00e1rez-Mutis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine S.","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana C. B.","family":"Luz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,26]]},"reference":[{"key":"998_CR1","unstructured":"Minist\u00e9rio da Sa\u00fade (Brasil). Secretaria de Vigil\u00e2ncia em Sa\u00fade (SVS)\/Departamento de Vigil\u00e2ncia Epidemiol\u00f3gica (DVE). Boletim Epidemiol\u00f3gico. In: Situa\u00e7\u00e3o epidemiol\u00f3gica da mal\u00e1ria no Brasil, 2000 a 2011. 2013. http:\/\/bvsms.saude.gov.br\/bvs\/periodicos\/boletim_epidemiologico_numero_1_2013.pdf . Accessed 14 January 2015."},{"key":"998_CR2","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1590\/0074-0276140228","volume":"109","author":"A Pina-Costa de","year":"2014","unstructured":"de Pina-Costa A, Brasil P, Di Santi SM, de Araujo MP, Su\u00e1rez-Mutis MC, Santelli AC, et al. Malaria in Brazil: what happens outside the Amazonian endemic region. Mem Inst Oswaldo Cruz. 2014;109:618\u201333.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"998_CR3","unstructured":"Minist\u00e9rio da Sa\u00fade (Brasil)\/Secretaria de Vigil\u00e2ncia em Sa\u00fade (SVS). Programa Nacional de Preven\u00e7\u00e3o e Controle da Mal\u00e1ria\u2014PNCM. Bras\u00edlia: FUNASA; 2003."},{"issue":"Suppl 1","key":"998_CR4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1590\/S0074-02762011000900013","volume":"106","author":"PL Tauil","year":"2011","unstructured":"Tauil PL. The prospect of eliminating malaria transmission in some regions of Brazil. Mem Inst Oswaldo Cruz. 2011;106(Suppl 1):105\u20136.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"998_CR5","unstructured":"Management Sciences for Health. Informe T\u00e9cnico: An\u00e1lisis de las pr\u00e1cticas de prescripci\u00f3n, dispensaci\u00f3n y adherencia al tratamiento antimal\u00e1rico en los pa\u00edses que comparten la Cuenca del Amazonas. In: Strengthening pharmaceutical systems (SPS). 2009. http:\/\/www.usaidami.org\/extras\/AdherencetoMalariaTreatmentsp.pdf . Accessed 14 April 2015."},{"key":"998_CR6","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","volume":"353","author":"LMD Osterberg","year":"2005","unstructured":"Osterberg LMD, Blaschke TMD. Drug therapy: adherence to medication. N Engl J Med. 2005;353:487\u201397.","journal-title":"N Engl J Med"},{"key":"998_CR7","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1146\/annurev-pharmtox-011711-113247","volume":"52","author":"TF Blaschke","year":"2012","unstructured":"Blaschke TF, Osterberg L, Vrijens B, Urquhart J. Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing histories. Annu Rev Pharmacol Toxicol. 2012;52:275\u2013301.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"998_CR8","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2125.2012.04167.x","volume":"73","author":"B Vrijens","year":"2012","unstructured":"Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73:691\u2013705.","journal-title":"Br J Clin Pharmacol"},{"key":"998_CR9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11096-013-9856-y","volume":"36","author":"R Ahmed","year":"2014","unstructured":"Ahmed R, Aslani P. What is patient adherence? A terminology overview. Int J Clin Pharm. 2014;36:4\u20137.","journal-title":"Int J Clin Pharm."},{"key":"998_CR10","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/bcp.12194","volume":"77","author":"TMU Nguyen","year":"2013","unstructured":"Nguyen TMU, La Caze A, Cottrell N. What are validated self-report adherence scales really measuring? A systematic review. Br J Clin Pharmacol. 2013;77:427\u201345.","journal-title":"Br J Clin Pharmacol"},{"key":"998_CR11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/1475-2875-13-321","volume":"13","author":"ED Almeida","year":"2014","unstructured":"Almeida ED, Rodrigues LC, Vieira JL. Estimates of adherence to treatment of vivax malaria. Malar J. 2014;13:321.","journal-title":"Malar J."},{"key":"998_CR12","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1590\/S0102-311X2007001000004","volume":"23","author":"LF Freitas","year":"2007","unstructured":"Freitas LF, Chaves GC, Wannmacher L, Osorio-de-Castro CGS. Mal\u00e1ria n\u00e3o-complicada por P. vivax e P. falciparum no Brasil: evid\u00eancias sobre f\u00e1rmacos isolados e associa\u00e7\u00f5es medicamentosas empregados em esquemas terap\u00eauticos recomendados pelo protocolo terap\u00eautico oficial. Cad Saude Publica. 2007;23:2285\u201394.","journal-title":"Cad Saude Publica."},{"key":"998_CR13","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1590\/S0102-311X2009000900021","volume":"25","author":"CGS Osorio-de-Castro","year":"2009","unstructured":"Osorio-de-Castro CGS, Chaves GC, Ruiz AM, Miranda ES, Campos MR, Su\u00e1rez-Mutis MC, et al. A proposal for an evaluation model of pharmaceutical services for malaria. Cad Saude Publica. 2009;25:2075\u201382.","journal-title":"Cad Saude Publica."},{"key":"998_CR14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/1475-2875-10-335","volume":"10","author":"MC Su\u00e1rez-Mutis","year":"2011","unstructured":"Su\u00e1rez-Mutis MC, de Souza PP, Freitas LF, Miranda ES, Campos MR, Osorio-de-Castro CG. Pharmaceutical services for endemic situations in the Brazilian Amazon: organization of services and prescribing practices for Plasmodium vivax and Plasmodium falciparum non-complicated malaria in high-risk municipalities. Malar J. 2011;10:335.","journal-title":"Malar J."},{"key":"998_CR15","volume-title":"How to investigate drug use in health facilities: select drug use indicators","author":"World Health Organization","year":"1993","unstructured":"World Health Organization. How to investigate drug use in health facilities: select drug use indicators. Geneva: WHO; 1993."},{"key":"998_CR16","unstructured":"Management Sciences for Health\/Rational Pharmaceutical Management Project (MSH\/RPMP). Rapid pharmaceutical management assessment: an indicator based approach. Arlington: MSH; 1995."},{"key":"998_CR17","volume-title":"Drug management for malaria manual","author":"M Clark","year":"2000","unstructured":"Clark M. Drug management for malaria manual. Arlington: MSH; 2000."},{"key":"998_CR18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fphar.2013.00091","volume":"4","author":"P Kardas","year":"2013","unstructured":"Kardas P, Lewek P, Matyjaszczyk M. Determinants of patient adherence: a review of systematic reviews. Front Pharmacol. 2013;4:91.","journal-title":"Front Pharmacol."},{"key":"998_CR19","volume-title":"Adherence to long-term therapies: evidence for action","author":"World Health Organization","year":"2003","unstructured":"World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: WHO; 2003."},{"key":"998_CR20","unstructured":"Abramson JH, Gahlinger PM. Computer programs for epidemiologists PEPI v.4.0. Salt Lake City: Sagebrush Press; 2001."},{"key":"998_CR21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159\u201374.","journal-title":"Biometrics."},{"key":"998_CR22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.actatropica.2012.11.004","volume":"125","author":"TC Luz","year":"2013","unstructured":"Luz TC, Su\u00e1rez-Mutis MC, Miranda ES, Moritz AF, Freitas LF, Brasil JC, et al. Uncomplicated malaria among pregnant women in the Brazilian Amazon: local barriers to prompt and effective case management. Acta Trop. 2013;125:137\u201342.","journal-title":"Acta Trop"},{"key":"998_CR23","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1590\/S0104-11692011000600002","volume":"19","author":"ACS Ferreira","year":"2011","unstructured":"Ferreira ACS, Su\u00e1rez-Mutis MC, Campos MR, Osorio-de-Castro CGS. Primary health care in municipalities at high risk for malaria. Rev Lat Am Enferm. 2011;19:1281\u20138.","journal-title":"Rev Lat Am Enferm."},{"key":"998_CR24","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1186\/1475-2875-10-355","volume":"10","author":"EA Pereira","year":"2011","unstructured":"Pereira EA, Ishikawa EAY, Fontes CJF. Adherence to Plasmodium vivax malaria treatment in the Brazilian Amazon Region. Malar J. 2011;10:355.","journal-title":"Malar J."},{"key":"998_CR25","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1046\/j.1365-3156.2003.01042.x","volume":"8","author":"EC Duarte","year":"2003","unstructured":"Duarte EC, Gyorkos TW. Self-reported compliance with last malaria treatment and occurrence of malaria during follow-up in a Brazilian Amazon population. Trop Med Int Health. 2003;8:518\u201324.","journal-title":"Trop Med Int Health."},{"key":"998_CR26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.5539\/gjhs.v6n3p37","volume":"6","author":"S Okuboyejo","year":"2014","unstructured":"Okuboyejo S. Non-adherence to medication in outpatient setting in Nigeria: the effect of employment status. Glob J Health Sci. 2014;6:37\u201344.","journal-title":"Glob J Health Sci."},{"key":"998_CR27","unstructured":"Minist\u00e9rio da Sa\u00fade (MS)\/Secretaria de Vigil\u00e2ncia em Sa\u00fade (SVS). SIVEP mal\u00e1ria. 2014. http:\/\/portalweb04.saude.gov.br\/sivep_malaria\/relatorio\/ rel_resumo_ nacional_mensal.asp?tx_opcao_agravo=MALARIA&opcao_agravo=B54%20&dt_inicial=01\/01\/2014&\u00a0dt_final=31\/12\/2014&niv_relatorio=NACIONAL. Accessed 06 April 2015."},{"key":"998_CR28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11096-013-9869-6","volume":"36","author":"A Caze La","year":"2013","unstructured":"La Caze A, Gujral G, Cottrell WN. How do we better translate adherence research into improvements in patient care? Int J Clin Pharm. 2013;36:10\u20134.","journal-title":"Int J Clin Pharm."},{"key":"998_CR29","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1590\/0074-0276140240","volume":"109","author":"FF Val","year":"2014","unstructured":"Val FF, Sampaio VS, Cassera MB, Andrade RT, Tauil PL, Monteiro WM, et al. Plasmodium vivax malaria elimination: should innovative ideas from the past be revisited? Mem Inst Oswaldo Cruz. 2014;109:522\u20134.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"998_CR30","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2147\/TCRM.S1458","volume":"4","author":"J Jin","year":"2008","unstructured":"Jin J, Sklar GE, Oh VMS, Li SC. Factors affecting therapeutic compliance: a review from the patient\u2019s perspective. Ther Clin Risk Manag. 2008;4:269\u201386.","journal-title":"Ther Clin Risk Manag"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-015-0998-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T23:56:44Z","timestamp":1567382204000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.malariajournal.com\/content\/14\/1\/471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,26]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["998"],"URL":"https:\/\/doi.org\/10.1186\/s12936-015-0998-3","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,26]]},"article-number":"471"}}